SurgePays, Inc. (SURG)

NasdaqCM • Currently down 0.03 (-23.74%) in today's trading session

1 member of Congress has disclosed 1 trade in SurgePays, Inc. (SURG) via STOCK Act filings. The most recent disclosure was a purchase by Brenda L. Lawrence on 12 July 2018. Aggregate disclosed activity totals roughly $8K in purchases (midpoint estimates from bracketed disclosure amounts).

SurgePays, Inc. is currently trading at $0.11, positioned at 0% of its 52-week range ($0.10 – $2.08).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$0.11
24h Change
-0.03 (-23.74%)
52 Week Range
$0.10–$2.08
View on NASDAQ

SurgePays, Inc. Price History and Technical Analysis

Congressional Trading Activity for SURG

Select to highlight on chart
1 transactions
Compliance: 100%
Brenda L. Lawrence12 Jul 201821 Aug 2019PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$5.61M

Volume

2.77M

Beta

0.28

P/E Ratio

-0.07

Fundamentals

EPS

$-1.52

Div. Yield

-

Open

$0.14

Day Range

$0.11 – $0.14

Company Information

Sector
Technology
Industry
Software - Application
Exchange
NASDAQ · USD
Country
US
CEO
Kevin Brian Cox
IPO Date
2018-01-17

SurgePays, Inc. operates as a financial technology and telecommunications enterprise dedicated to serving the underbanked communities across the United States. A core component of its strategy is a blockchain-powered platform that transforms local co...

Earnings

Next Report

Q3 2026

25 Nov

EPS Est.

$-0.07

Rev. Est.

$16.5M

Days Until

3

Recent Quarters

Q3 202620 Nov
EPS-
Q3 202619 Nov
EPS-
Q3 202618 Nov
EPS-
Q3 202616 Nov
EPS-
Q3 202611 Nov
EPS-
Q2 202614 Aug
EPS$0.05
Beat 145.4%
Q1 202615 May
EPS$-0.51
Miss 168.4%
Q1 202614 Apr
EPS$-0.68
Miss 195.7%
Q3 202512 Nov
EPS$-0.38
Miss 123.5%
Q2 202513 Aug
EPS$-0.36
Miss 16.1%
Q1 202513 May
EPS$-0.38
Beat 5.0%
Q4 202425 Mar
EPS$-0.93
Miss 244.4%
Q3 202412 Nov
EPS$-0.73
Miss 231.8%
Q2 202413 Aug
EPS$-0.66
Miss 288.2%
Q1 202413 May
EPS$0.07
Miss 53.3%
Q4 202312 Mar
EPS$0.20
Miss 51.2%
Q3 202314 Nov
EPS$0.49
Beat 75.0%
Q2 202310 Aug
EPS$0.40
Beat 150.0%
Q1 202311 May
EPS$0.31
Beat 1133.1%
Q4 202230 Mar
EPS$0.25
Beat 327.3%
Q3 202214 Nov
EPS$-0.12
Miss 141.4%
Q2 202211 Aug
EPS$-0.07
Miss 799.7%
Q1 202216 May
EPS$-0.10
Miss 150.0%
Q4 202124 Mar
EPS$-0.88
Miss 2299.8%
Q3 202115 Nov
EPS$-0.51
Q2 202120 Aug
EPS$-0.07
Q1 202117 May
EPS$-1.85
Q1 20212 Apr
EPS$-1.16
Q3 202017 Nov
EPS$-1.09
Q2 202014 Aug
EPS$-1.14
Q1 202022 Jun
EPS$-1.47
Q1 202012 May
EPS$-1.65
Q3 201914 Nov
EPS$-0.59
Q2 201914 Aug
EPS$-1.32
Q1 201915 May
EPS$-0.93
Q1 20191 Apr
EPS$-0.70
Q3 201814 Nov
EPS$-0.25
Q2 201814 Aug
EPS$-0.23
Q1 201821 May
EPS$-0.17
Q1 201810 Apr
EPS$0.19
Q4 20178 Jan
EPS$-0.17
Q4 20174 Jan
EPS$-0.66
Q4 20172 Jan
EPS$-0.82
Q3 201711 Dec
EPS$-2.19
Q3 201621 Nov
EPS$-0.94
Q2 201622 Aug
EPS$-1.49
Q1 201620 May
EPS$-1.06
Q1 201614 Apr
EPS$-1.35
Q3 20157 Nov
EPS$-0.27
Q2 20154 Sept
EPS$-0.30
Q4 201431 Mar
EPS$-0.09
Q4 20149 Mar
EPS$-1.41
Q3 20145 Dec
EPS$-1.63
Q2 20145 Sept
EPS$-1.41
Q2 201425 Jul
EPS$1.05
Q4 201313 Mar
EPS$-1.54
Q3 20139 Dec
EPS$-0.94
Q2 201311 Sept
EPS$-1.54
Q2 201326 Jul
EPS$-0.57
Q4 201214 Mar
EPS$-0.71
Q3 201214 Dec
EPS$-1.19
Q2 201211 Sept
EPS$-0.86
Q2 201223 Jul
EPS$-3.44
Q4 20116 Mar
EPS$-19.15
Q3 201114 Dec
EPS$-6.76
Q2 201114 Sept
EPS$-5.62
Q2 20111 Jul
EPS$-2.69
Q4 201015 Mar
EPS$-4.74
Q3 20107 Dec
EPS$-11.17
Q2 201013 Sept
EPS$-10.86
Q2 201029 Jul
EPS$-52.67
Q4 20099 Mar
EPS$-12.04
Q3 200921 Dec
EPS$-21.28
Q2 200921 Sept
EPS$-13.18
Q2 20097 Aug
EPS$-1010.65
Q4 200823 Mar
EPS$-38.16
Q3 200812 Dec
EPS$-148.08
Q2 200815 Sept
EPS$-14.65
Q1 20089 Apr
EPS$-4.24
Q4 200717 Mar
EPS$-2.11
Q3 200715 Oct
EPS$-66.16
Q2 200717 Jul
EPS$-94.18
Q1 200714 May
EPS$-21.63

No dividend data available for this stock.

Stock Splits

Split History

2 Nov 2021Reverse Split
Ratio1:50
31 Mar 2015Reverse Split
Ratio1:23
18 May 2009Reverse Split
Ratio1:50
21 Jul 2008Stock Split
Ratio3:2

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

NVDA

NVIDIA Corporation

57
$125.53-20.45 (-14.01%)
Technology
Held by same politician
Same sector: Technology
+1 more reason
1 politician
View Stock

AAPL

Apple Inc.

47
$342.56-6.65 (-1.90%)
Technology
Held by same politician
Same sector: Technology
1 politician
View Stock

AMD

Advanced Micro Devices, Inc.

47
$424.39-64.80 (-13.25%)
Technology
Held by same politician
Same sector: Technology
1 politician
View Stock

Frequently Asked Questions about SURG

Which members of Congress have traded SURG?
1 member of Congress has disclosed 1 trade in SurgePays, Inc. (SURG) under the STOCK Act: Brenda L. Lawrence.
When was SURG most recently disclosed by Congress?
The most recent SURG disclosure was a purchase by Brenda L. Lawrence on 12 July 2018.
What is the total disclosed congressional trading volume for SURG?
Members of Congress have disclosed approximately $8K in SURG purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in SURG?
This SURG page updates as soon as new STOCK Act disclosures are filed for SurgePays, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.